The detection of diseases at an early stage of development provides many benefits, such as timely and specific treatment with considerable cost savings and the ability to trace the cause of an illness. To support the progress of early diagnostics, VITO focuses on the development of diagnostic assays and technologies, and on the identification of new biomarkers. We do this in close collaboration with academic partners, health experts and the pharmaceutical and biotech industries.

Publications

Artificial Intelligence Software for Diabetic Eye Screening: Diagnostic Performance and Impact of Stratification
Year: 
2023
Journal: 
JOURNAL OF CLINICAL MEDICINE
Peeters, F; Rommes, S; Elen, B; Gerrits, N; Stalmans, I; Jacob, J; De Boever, P
Macrophages Release Extracellular Vesicles of Different Properties and Composition Following Exposure to Nanoparticles
Year: 
2023
Journal: 
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Deville, S; Romeu, HG; Oeyen, E; Mertens, I; Nelissen, I; Salvati, A
Intravesicular Genomic DNA Enriched by Size Exclusion Chromatography Can Enhance Lung Cancer Oncogene Mutation Detection Sensitivity
Year: 
2022
Journal: 
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Van Hoof, R; Deville, S; Hollanders, K; Berckmans, P; Wagner, P; Hooyberghs, J; Nelissen, I
Retinal vessel multifractals predict pial collateral status in patients with acute ischemic stroke
Year: 
2022
Journal: 
PLOS ONE
Khan, A; De Boever, P; Gerrits, N; Akhtar, N; Saqqur, M; Ponirakis, G; Gad, H; Petropoulos, IN; Shuaib, A; Faber, JE; Kamran, S; Malik, RA
Polymer-tethered glycosylated gold nanoparticles recruit sialylated glycoproteins into their protein corona, leading to off-target lectin binding
Year: 
2022
Journal: 
NANOSCALE
Ahmad, A; Georgiou, PG; Pancaro, A; Hasan, M; Nelissen, I; Gibson, MI

Pages